News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
CRISPR 2.0, the Next Generation
June 21, 2024
Aspen Ideas: Health
CRISPR 2.0, the Next Generation
June 21, 2024
All Stories
News
Scribe: engineering CRISPR’s next generation
October 6, 2020
BioCentury
Read Now
Press Release
Scribe: engineering CRISPR’s next generation
October 6, 2020
BioCentury
Read Now
News
Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter
October 6, 2020
BioXconomy
Read Now
Press Release
Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter
October 6, 2020
BioXconomy
Read Now
News
Doudna Inc.: How Cal scientist created a biotech startup engine
October 6, 2020
San Francisco Business Times
Read Now
Press Release
Doudna Inc.: How Cal scientist created a biotech startup engine
October 6, 2020
San Francisco Business Times
Read Now
News
The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased
October 6, 2020
Endpoints News
Read Now
Press Release
The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased
October 6, 2020
Endpoints News
Read Now